Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 1/2008

01-03-2008 | Original Article

Percutaneous endovascular abdominal aortic aneurysm repair leads to a reduction in wound complications

Authors: C. O. McDonnell, M. V. Forlee, J. F. Dowdall, M.-P. Colgan, P. Madhavan, G. D. Shanik, D. J. Moore

Published in: Irish Journal of Medical Science (1971 -) | Issue 1/2008

Login to get access

Abstract

Introduction

While endovascular aortic aneurysm repair (EVAR) has significantly reduced the morbidity associated with open surgery, efforts continue to minimise the surgical insult to the patient. We report our experience of percutaneous EVAR.

Patients and methods

Since June 2005, 17/20 EVARs (85%) have been attempted percutaneously by deployment of two Perclose© devices into each femoral artery prior to passage of the device sheath. The sutures are left untied until the sheath is removed at the end of the procedure, when haemostasis is obtained. Patients were entered onto a prospectively maintained database and followed up at regular intervals in a dedicated EVAR clinic.

Results

Access and subsequent graft deployment was successful in all the 17 cases. The range of defects closed ranged from 12–24 Fr. Five patients (29%) required open groin exploration at the end of the procedure to achieve haemostasis. There was a significantly lower incidence of wound complications in the percutaneous EVAR group (6 vs. 10% open cutdown cases, P < 0.05, Mann–Whitney U test).

Conclusion

Percutaneous EVAR is both a feasible and safe method of performing endovascular abdominal aortic aneurysm repair, which is associated with a reduction in wound complication rates.
Literature
1.
go back to reference EVAR (2005) Trial participants endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. Lancet 365(9478):2179–2186CrossRef EVAR (2005) Trial participants endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. Lancet 365(9478):2179–2186CrossRef
2.
go back to reference Prinssen M, Buskens E, Blankensteijn JD (2004) DREAM trial participants. Quality of life endovascular and open AAA repair. Results of a randomised trial. Eur J Vasc Endovasc Surg 27(2):121–127PubMedCrossRef Prinssen M, Buskens E, Blankensteijn JD (2004) DREAM trial participants. Quality of life endovascular and open AAA repair. Results of a randomised trial. Eur J Vasc Endovasc Surg 27(2):121–127PubMedCrossRef
3.
go back to reference Teh LG, Sieunarine K, van Schie G et al (2001) Use of the percutaneous vascular surgery device for closure of femoral access sites during endovascular aneurysm repair: lessons from our experience. Eur J Vasc Endovasc Surg 22(5):418–423PubMedCrossRef Teh LG, Sieunarine K, van Schie G et al (2001) Use of the percutaneous vascular surgery device for closure of femoral access sites during endovascular aneurysm repair: lessons from our experience. Eur J Vasc Endovasc Surg 22(5):418–423PubMedCrossRef
4.
go back to reference Traul DK, Clair DG, Gray B, O’Hara PJ, Ouriel K (2000) Percutaneous endovascular repair of infrarenal abdominal aortic aneurysms: a feasibility study. J Vasc Surg 32(4):770–776PubMedCrossRef Traul DK, Clair DG, Gray B, O’Hara PJ, Ouriel K (2000) Percutaneous endovascular repair of infrarenal abdominal aortic aneurysms: a feasibility study. J Vasc Surg 32(4):770–776PubMedCrossRef
5.
go back to reference Howell M, Doughtery K, Strickman N, Krajeer Z (2002) Percutaneous repair of abdominal aortic aneurysms using the AneuRx stent graft and the percutaneous vascular surgery device. Catheter Cardiovasc Interv 55(3):281–287PubMedCrossRef Howell M, Doughtery K, Strickman N, Krajeer Z (2002) Percutaneous repair of abdominal aortic aneurysms using the AneuRx stent graft and the percutaneous vascular surgery device. Catheter Cardiovasc Interv 55(3):281–287PubMedCrossRef
6.
go back to reference Rachel ES, Bergamini TM, Kinney EV et al (2002) Percutaneous endovascular abdominal aortic aneurysm repair. Ann Vasc Surg 16(1):43–49PubMedCrossRef Rachel ES, Bergamini TM, Kinney EV et al (2002) Percutaneous endovascular abdominal aortic aneurysm repair. Ann Vasc Surg 16(1):43–49PubMedCrossRef
7.
go back to reference Torsello GB, Kasprzak B, Klenk E et al (2003) Endovascular suture versus cutdown for endovascular aneurysm repair: a prospective randomised pilot study. J Vasc Surg 38(1):78–82PubMedCrossRef Torsello GB, Kasprzak B, Klenk E et al (2003) Endovascular suture versus cutdown for endovascular aneurysm repair: a prospective randomised pilot study. J Vasc Surg 38(1):78–82PubMedCrossRef
8.
go back to reference Morasch MD, Kibbe MR, Evans ME, et al (2004) Percutaneous repair of abdominal aortic aneurysm. J Vasc Surg 40(1):12–16PubMedCrossRef Morasch MD, Kibbe MR, Evans ME, et al (2004) Percutaneous repair of abdominal aortic aneurysm. J Vasc Surg 40(1):12–16PubMedCrossRef
9.
go back to reference Borner G, Ivancev K, Sonesson B, et al (2004) Percutaneous AAA repair: is it safe? J Endovasc Ther 11(6):621–626PubMedCrossRef Borner G, Ivancev K, Sonesson B, et al (2004) Percutaneous AAA repair: is it safe? J Endovasc Ther 11(6):621–626PubMedCrossRef
Metadata
Title
Percutaneous endovascular abdominal aortic aneurysm repair leads to a reduction in wound complications
Authors
C. O. McDonnell
M. V. Forlee
J. F. Dowdall
M.-P. Colgan
P. Madhavan
G. D. Shanik
D. J. Moore
Publication date
01-03-2008
Publisher
Springer-Verlag
Published in
Irish Journal of Medical Science (1971 -) / Issue 1/2008
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-008-0122-6

Other articles of this Issue 1/2008

Irish Journal of Medical Science (1971 -) 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.